Dr. Nasreen A. Vohra
Claim this profileEast Carolina University
Studies Melanoma
Studies Cutaneous Melanoma
5 reported clinical trials
10 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
Stage II
2Cutaneous Melanoma
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Nasreen A. Vohra is currently running
Surgical Excision Margins
for Melanoma
Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.
Recruiting1 award N/A9 criteria
Biomarker-Guided Immunotherapy Discontinuation
for Melanoma
This trial uses drugs that boost the immune system to fight advanced melanoma that can't be surgically removed. It aims to see if doctors can safely shorten the treatment period by using imaging tests to guide decisions. Pembrolizumab and ipilimumab are immunotherapy drugs used to treat advanced melanoma, with pembrolizumab approved for younger patients and ipilimumab showing positive results in previous studies.
Recruiting1 award Phase 222 criteria
More about Nasreen A. Vohra
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Nasreen A. Vohra has experience with
- Pembrolizumab
- Therapeutic Conventional Surgery
- Ipilimumab
- Nivolumab
- Cisplatin
- Gemcitabine Hydrochloride
Breakdown of trials Nasreen A. Vohra has run
Melanoma
Cutaneous Melanoma
Merkel Cell Carcinoma
Gallbladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nasreen A. Vohra specialize in?
Nasreen A. Vohra focuses on Melanoma and Cutaneous Melanoma. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Nasreen A. Vohra currently recruiting for clinical trials?
Yes, Nasreen A. Vohra is currently recruiting for 2 clinical trials in Greenville North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Nasreen A. Vohra has studied deeply?
Yes, Nasreen A. Vohra has studied treatments such as Pembrolizumab, Therapeutic Conventional Surgery, Ipilimumab.
What is the best way to schedule an appointment with Nasreen A. Vohra?
Apply for one of the trials that Nasreen A. Vohra is conducting.
What is the office address of Nasreen A. Vohra?
The office of Nasreen A. Vohra is located at: East Carolina University, Greenville, North Carolina 27834 United States. This is the address for their practice at the East Carolina University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.